← Leaderboards
Fidel Rubagumya
Research For Development
$418,927
Attributed
$804,039
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $351.4K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$804,039 · 1
By mechanism
UG1$804,039 · 1
Top collaborators
- Kathryn M Anastos2 shared
- Gad Murenzi2 shared
Others in their field
Other Rising Stars on “Women&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Karen L Florio · University Of Missouri Kansas City$2,288,976
- Abbi Danielle Lane · University Of Michigan At Ann Arbor$2,125,559
- Jeremy Joseph Pruzin · Utah State Higher Education System--University Of Utah$1,929,922
- Sanika Samuel Chirwa · Meharry Medical College$1,756,675
- Tatyana Kushner · Icahn School Of Medicine At Mount Sinai$1,387,120
Research focus
Women&AposClinical TrialsCervicalAdherence12 Year OldAcceptability And FeasibilityAdenocarcinoma In SituAfrica South Of The SaharaAntiretroviral TherapyAttributable MortalityCancer BurdenAfricaCancer InvasivenessCentral Africa15 Year OldCervical Cancer PreventionCervical Cancer ScreeningCervical Intraepithelial NeoplasiaCervix UteriCessation Of LifeChronic InfectionClinicClinically SignificantClinical Trial Protocol